MYGN

Myriad Genetics, Inc. News Headlines

$36.02
*  
0.40
1.1%
Get MYGN Alerts
*Delayed - data as of Dec. 22, 2014 14:17 ET  -  Find a broker to begin trading MYGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    MYGN Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Myriad Genetics Appoints Bernard Tobin As President Of Crescendo Bioscience
12/22/2014 7:17:00 AM - RTT News


JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice
12/21/2014 11:36:00 PM - RTT News


Myriad Genetics Breaks Above 200-Day Moving Average - Bullish for MYGN
12/19/2014 4:31:46 PM - BNK Invest


Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha


Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst Blog
12/17/2014 4:50:00 PM - Zacks.com


Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst Blog
12/17/2014 4:50:00 AM - Investopedia


Myriad Genetics Unveils Positive Cancer Study Results - Analyst Blog
12/10/2014 1:30:00 PM - Zacks.com


Genomic Health's Oncotype DX: Cancer Testing Made Easier - Analyst Blog
12/4/2014 2:40:00 PM - Zacks.com


Myriad Genetics' Prolaris: A Pocket-Friendly Cancer Test - Analyst Blog
12/3/2014 2:00:00 PM - Zacks.com


Stocks Remain Mostly Positive In Mid-Day Trading - U.S. Commentary
11/24/2014 12:17:00 PM - RTT News


Myriad Genetics, Tesaro Tie Up for myChoice Cancer Test - Analyst Blog
11/21/2014 3:10:00 PM - Zacks.com


Myriad's Vectra DA: A Better Indicator for Rheumatoid Arthritis - Analyst Blog
11/20/2014 3:00:00 PM - Zacks.com


TESARO, Myriad Announce Companion Diagnostics Collaboration - Quick Facts
11/20/2014 8:23:00 AM - RTT News


Update: Myriad Genetics Q1 FY 2015 Earnings
11/15/2014 8:30:00 AM - Seeking Alpha


Myriad Genetics To Present At Credit Suisse Conference; Webcast At 3:00 PM ET
11/12/2014 2:00:00 PM - RTT News


Myriad Genetics Down on Earnings, Revenue Miss in Q1 - Analyst Blog
11/6/2014 3:30:00 PM - Zacks.com


Wall Street Seeking To Regain Momentum
11/5/2014 6:30:00 AM - RTT News


Myriad Genetics Q1 Results Miss Estimates, Issues Weak Q2 Outlook
11/4/2014 10:01:00 PM - RTT News


Myriad Genetics Q1 Profit Decreases - Quick Facts
11/4/2014 6:08:00 PM - RTT News


Myriad Genetics Q1 15 Earnings Conference Call At 4:30 PM ET
11/4/2014 3:00:00 PM - RTT News


Earnings Reaction History: Myriad Genetics Inc., 33.3% Follow-Through Indicator, 6.5% Sensitive
11/4/2014 2:34:44 PM - MT Newswires


Weakness Seen in Myriad (MYGN): Stock Tumbles 7.2% - Tale of the Tape
10/20/2014 8:14:18 AM - Zacks.com


Myriad Genetics Breaks Below 200-Day Moving Average - Notable for MYGN
10/17/2014 10:50:40 AM - BNK Invest


Novavax (NVAX) Moves Up: Stock Adds 10.1% in Session - Tale of the Tape
10/17/2014 8:39:00 AM - Zacks.com


Lexicon Pharmaceuticals (LXRX) Jumps: Stock Rises 15.7% - Tale of the Tape
10/17/2014 7:51:00 AM - Zacks.com